The repertoire of equine intestinal α-defensins

por Bruhn, Oliver, Paul, Sven, Tetens, Jens, Thaller, Georg
Publicado 2009

Antimicrobial peptides and proteins of the horse - insights into a well-armed organism

por Bruhn, Oliver, Grötzinger, Joachim, Cascorbi, Ingolf, Jung, Sascha
Publicado 2011

OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications

por Böhm, Ruwen, von Hehn, Leocadie, Herdegen, Thomas, Klein, Hans-Joachim, Bruhn, Oliver, Petri, Holger, Höcker, Jan
Publicado 2016

Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, S...

por Klümper, Theresa, Bruckmueller, Henrike, Diewock, Tobias, Kaehler, Meike, Haenisch, Sierk, Pott, Christiane, Bruhn, Oliver, Cascorbi, Ingolf
Publicado 2020

MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells

por Kaehler, Meike, Ruemenapp, Johanna, Gonnermann, Daniel, Nagel, Inga, Bruhn, Oliver, Haenisch, Sierk, Ammerpohl, Ole, Wesch, Daniela, Cascorbi, Ingolf, Bruckmueller, Henrike
Publicado 2017